B.Riley/FBR Resumes Infinity Pharmaceutical (INFI) at Buy
Tweet Send to a Friend
B.Riley/FBR analyst Andrew D\'Silva resumes coverage on Infinity Pharmaceutical (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
